Sparsentan CAS 254740-64-2 99% Purity Dual Endothelin and Angiotensin II Receptor Antagonist API Intermediate for Kidney Disease Research fk
TDS 2 Inquiries
254740-64-2
Reagent Grade
99%
qingdao
//
10mg, 25mg, 50mg, 100mg, 1g
Yes
2026-10-26
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSparsentan has been used in trials studying the treatment of Focal Segmental Glomerulosclerosis. Sparsentan is the first and only dual-acting angiotensin and endothelin receptor antagonist (DARA) in development.Research & Reference Note
Sparsentan CAS 254740-64-2 99% Purity Dual Endothelin and Angiotensin II Receptor Antagonist API Intermediate for Kidney Disease Research fk is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
Sparsentan(RE-021)
Other Name:4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide;Sparsentan (RE-021);Sparsentan-d5 (RE-021-d5);RE 201;[1,1'-Biphenyl]-2-sulfonamide, 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-;Sparsentan;4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide;BMS-346567
CAS No.:254740-64-2
Molecular Formula:C32H40N4O5S
InChIKeys:WRFHGDPIDHPWIQ-UHFFFAOYSA-N
Molecular Weight:592.75
Exact Mass:592.27194156
UNII:9242RO5URM
Categories:
Characteristics-
PSA:
122.48000
XLogP3:7.06670
Density:1.28±0.1 g/cm3
Melting Point:148 °C(Solv: isopropanol (67-63-0); water (7732-18-5))
Boiling Point:744.4±70.0 °C(Predicted)
PKA:7.06±0.50
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted
India
Sprasentan
5 G Oct 28, 2025
Bangladesh
Sparsentan
1000 KG Sep 18, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Clascoterone CAS 19608-29-8 Topical Androgen Receptor Antagonist for Acne and Alopecia hfd
Reagent Grade / 99%
$100-130/G FOB
-